NEFRONA 与 PECERA 两个研究,均通过队列观察发现,骨矿物质参数如钙、磷、PTH,与 CKD 进展和心血管事件发生率密切相关;对于尚未进入透析的 CKD 4 - 5 期患者,积极地控制血清钙、磷、PTH,具有潜在的生存获益。 COSMOS 研究表明血磷在 1.42 mmol/L 时透析患者死亡风险最低,而此次的 PECERA 研究结论表示未进入透...
Metabolic acidosis in stage 5 may manifest as protein-energy malnutrition, loss of lean body mass, and muscle weakness. Altered salt and water handling by the kidney in CKD can cause peripheral edema and, not uncommonly, pulmonary edema and hypertension. Anemia, which in CKD develops primarily ...
Rationale & Objective The associations between ischemic stroke and time to dialysis initiation and/or death in adults with late-stage chronic kidney disease (CKD) have not been explored. We sought to measure the rate and factors associated with stroke in CKD stages 4 and 5 and to assess the ...
NEFRONA 与 PECERA 两个研究,均通过队列观察发现,骨矿物质参数如钙、磷、PTH,与 CKD 进展和心血管事件发生率密切相关;对于尚未进入透析的 CKD 4 - 5 期患者,积极地控制血清钙、磷、PTH,具有潜在的生存获益。 COSMOS 研究表明血磷在 1.42 mmol/L 时透析患者死亡风险最低,而此次的 PECERA 研究结论表示未进入透...
attendant functional cardiovascular consequences between CKD stage 4 patients and both peritoneal dialysis (PD) and haemodialysis (HD) (CKD stage 5) patients... M Sigrist,P Bungay,MW Taal,... - 《Nephrology Dialysis Transplantation》 被引量: 433发表: 2006年 Prevalence and risk factors associated...
StageKidneyDamage++NANANAeGFR*(ml/min/1.73m2)≥9060-8930-5915-29<15(ordialysis)12345 (*calculatedfromserumcreatininelevelbytheabbreviatedMDRDequation;NA=notapplicable:findingsmustpersistfor≥3months)TheKDOQI-CKDClassificationSystemBenefits (RealandPerceived)BroughtordertothechaosofnosologyofCKD ...
Congestive heart failure, coronary artery disease, stroke or peripheral vascular disease frequency was lower than 10% The prevalence of eGFR < 60 ml/min x 1.73 m(2) was: stage 3 (30-59 ml/min/1.73 m(2)) 19.7%; stage 4 (15-29 ml/min/1.73 m(2)) 1.2%; stage 5 no dialysis (...
This study has a dual purpose: a) to examine the prevalence of heart diseases in general and HF episodes in particular, and determine their influence on the EPO doses administered in a representative sample of our stage 4-5 CKD patients; b) use this CKD population to prospectively study ...
Mehrotra52 (2008) 2892; % Hispanic NA; CKD3-4 NHANES III 24% 9 Age, sex, HTN, cholesterol, BMI, DM, smoking, family history of premature CVD, stage of CKD 1.26 (0.84-1.90)a Derose18 (2013) 1,119,816b; 31% Hispanic KP Southern California __c 5 Age, sex, entry eGFR 0.67 (...
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 2000, 342, 1478–1483. [Google Scholar] [CrossRef] Ketteler, M.; Liangos, O.; Biggar, P.H. Treating hyperphosphatemia–Current and advancing drugs. Expert Opin. ...